Literature DB >> 27927025

"Whenever I can I push myself to go to work": a qualitative study of experiences of sickness presenteeism among workers with rheumatoid arthritis.

Paula Holland1,2, Alison M Collins3.   

Abstract

PURPOSE: UK government policy emphasizes the importance of continuing to work for recovery from poor health, yet sickness presenteeism (going to work whilst ill) is commonly regarded as having negative consequences for organizations and individuals. Our study explores experiences of working after onset of rheumatoid arthritis (RA), a chronic musculoskeletal disorder characterized by high rates of work disability.
MATERIALS AND METHODS: An exploratory qualitative study consisting of in-depth interviews and six-month follow-up with 11 men and women with RA employed at disease onset.
RESULTS: We expand upon previous models of sickness presenteeism by distinguishing between presenteeism that occurs voluntarily (wanting to work despite illness) and involuntarily (feeling pressured to work when ill). RA onset affected participants' ability to work, yet motivation to remain working remained high. The implementation of workplace adjustments enabled participants to stay working and restore their work capacity. Conversely, managers' misinterpretation of organizational sickness absence policies could lead to involuntary presenteeism or delayed return to work, conflicting with the notion of work as an aid to recovery.
CONCLUSION: Workplace adjustments can facilitate voluntary sickness presenteeism. To reduce work disability and sickness absence, organizational policies should be sufficiently flexible to accommodate the needs of workers with fluctuating conditions. Implications for rehabilitation Individuals with rheumatoid arthritis (RA) are at high risk of work disability. Individuals' motivation to remain in work following onset of RA remains high, yet sickness presenteeism (working while ill) has received largely negative attention. It is important to distinguish between voluntary and involuntary forms of sickness presenteeism. Workplace adjustments facilitate voluntary sickness presenteeism (wanting to work despite illness) and improve job retention and productivity among workers with RA. Involuntary presenteeism (feeling pressured to work while ill) may occur if organizational policies are not sufficiently flexible to accommodate the needs of workers with RA.

Entities:  

Keywords:  Sickness presenteeism; musculoskeletal disorders; organizational policy; rheumatoid arthritis; sickness absence; workplace adjustments

Mesh:

Year:  2016        PMID: 27927025     DOI: 10.1080/09638288.2016.1258436

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  5 in total

1.  Reasons for presenteeism in different occupational branches in Sweden: a population based cross-sectional study.

Authors:  Staffan Marklund; Klas Gustafsson; Gunnar Bergström; Constanze Leineweber
Journal:  Int Arch Occup Environ Health       Date:  2021-04-29       Impact factor: 3.015

2.  Factors associated with limitations in daily life and at work in a population with shoulder pain.

Authors:  Diane Godeau; Marc Fadel; Alexis Descatha
Journal:  BMC Musculoskelet Disord       Date:  2022-08-15       Impact factor: 2.562

3.  Management of Chronic Musculoskeletal Disorders in the Workplace from the Perspective of Older Employees: A Mixed Methods Research Study.

Authors:  Glykeria Skamagki; Christine Carpenter; Andrew King; Charlotte Wåhlin
Journal:  Int J Environ Res Public Health       Date:  2022-07-30       Impact factor: 4.614

4.  Exploring the Health Impacts and Inequalities of the New Way of Working: Findings From a Cross-Sectional Study.

Authors:  Melda Lois Griffiths; Benjamin J Gray; Richard G Kyle; Jiao Song; Alisha R Davies
Journal:  J Occup Environ Med       Date:  2022-06-21       Impact factor: 2.306

5.  Home-Based Telework and Presenteeism Across Europe.

Authors:  Corinna Steidelmüller; Sophie-Charlotte Meyer; Grit Müller
Journal:  J Occup Environ Med       Date:  2020-12       Impact factor: 2.306

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.